Business Context and Reporting Period
Company: Probe Manufacturing, Inc. (Note: Request metadata referenced "Clean Energy Technologies, Inc.", but the filing text identifies the company as Probe Manufacturing, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: October 21, 2014
Event: Entry into a Letter of Intent (LOI) with S-Ray Incorporated regarding a potential share exchange and strategic partnership.
Key Financial Metrics
The filing text does not provide specific financial statements, revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period. This document reports a corporate event rather than periodic financial results.
Material Changes and Transaction Details
- Share Exchange Proposal: The Company intends to issue 75,000,000 shares of restricted common stock to S-Ray in exchange for 1,000,000 shares of S-Ray restricted common stock.
- Shareholder Distribution: The 1,000,000 S-Ray shares are to be distributed pro-rata to Probe Manufacturing shareholders of record as of October 31, 2014.
- Debt Restructuring: S-Ray has agreed to work with existing note holders regarding the potential extinguishment of existing notes upon closing.
- Commercial Agreement: S-Ray would commit to a manufacturing and distribution rights agreement for the "ClearScan LAB" (also referred to as "ClearView LAB") product.
Guidance, Outlook, and Risks
Management Commentary and Terms
- Revenue Recognition: Under the proposed distribution agreement, Probe Manufacturing would book revenue from product sales.
- Profit Control: The Company would maintain control of manufacturing costs and profits.
- Royalty Structure: S-Ray would receive an annual royalty of 6% of total ClearView LAB revenue.
- Term: The distribution rights agreement would last a minimum of 3 years and a maximum of 5 years.
- Capital Support: S-Ray intends to assist the Company in raising capital, purchasing equipment, and establishing commercial banking services (credit lines and debt).
Risks and Contingencies
- Non-Binding Nature: The transaction is based on a Letter of Intent and is subject to finalization of a Share Exchange Agreement.
- Approvals Required: The transaction requires shareholder approval and is subject to a due diligence period of up to 60 days.
- Timeline: The parties aim to close by December 20, 2014, but this is not guaranteed.
Investor Verification Checklist
- Verify the exact number of outstanding shares to assess the dilution impact of issuing 75,000,000 new shares.
- Confirm the status and terms of existing notes to understand the likelihood of debt extinguishment.
- Review the due diligence findings on S-Ray Incorporated prior to shareholder voting.
- Clarify the discrepancy between "ClearScan LAB" and "ClearView LAB" product names in the agreement terms.
- Monitor the shareholder vote scheduled for the proposed closing date.